This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Should All Newly Diagnosed Cardiomyopathies be Screened for Coronary Artery Disease?
The authors provide an excellent overview of the rationale for screening all patients with a new diagnosis of cardiomyopathy for coronary artery disease. This rationale includes the following:
- Two-thirds of patients with HF and reduced EF have CAD.
- Patients with CAD may deny angina, especially diabetics and females.
- Even without risk factors, more than 10% of HF patients have CAD.
- The important benefit of revascularization and secondary prevention in patients with CAD.